Case Report
Metastatic small cell neuroendocrine carcinoma of the breast
Alan S. Boyd,
Benjamin B. Hayes,
Corresponding Author
Alan S. Boyd
Department of Medicine (Dermatology), Vanderbilt University, Nashville, TN, USA
Department of Pathology, Vanderbilt University, Nashville, TN, USA
Alan S. Boyd, MD,
719 Thompson Lane, Suite 26300, Nashville, TN 37204, USA
Tel: +1 615 322 6485
Fax: +1 615 343 2591
e-mail: [email protected]
Search for more papers by this authorBenjamin B. Hayes
Spring Hill Dermatology and Allergy Clinic, Spring Hill, TN, USA
Search for more papers by this authorAlan S. Boyd,
Benjamin B. Hayes,
Corresponding Author
Alan S. Boyd
Department of Medicine (Dermatology), Vanderbilt University, Nashville, TN, USA
Department of Pathology, Vanderbilt University, Nashville, TN, USA
Alan S. Boyd, MD,
719 Thompson Lane, Suite 26300, Nashville, TN 37204, USA
Tel: +1 615 322 6485
Fax: +1 615 343 2591
e-mail: [email protected]
Search for more papers by this authorBenjamin B. Hayes
Spring Hill Dermatology and Allergy Clinic, Spring Hill, TN, USA
Search for more papers by this authorAbstract
Cutaneous metastases from internal malignancies in women overwhelmingly emanate from the breast and typically exhibit features of an adenocarcinoma, although other histopathologic patterns may also be seen. Neuroendocrine breast carcinoma represents an uncommon variant of mammary carcinoma with fewer than 40 cases of the small cell subcategory reported. As with other small cell carcinomas, they may exhibit Merkel cell-like features and appropriate diagnosis of these tumor deposits often turns on clinical history and an appropriate immunohistochemical profile. Herein, we report the first known patient with cutaneous metastases from a small cell neuroendocrine breast carcinoma.
References
- 1Ellis IO, Schnitt SJ, Sastre-Carau X, et al. Tumours of the breast, neuroendocrine tumours. In FA Tavassoli, P Devilee, eds. World Health Organization classification of tumours: pathology and genetics of tumours of the breast and female genital organs. WHO Classification of Tumors Series. Lyon: IARC Press, 2003; 32.
- 2Kitakata H, Yasumoto K, Sudo Y, Minato H, Takahashi Y. A case of primary small cell carcinoma of the breast. Breast Cancer 2007; 14: 414.
- 3Rovera F, Masciocchi P, Coglitore A, et al. Neuroendocrine carcinomas of the breast. Int J Surg 2008; 6: S113.
- 4Stita W, Trabelsi A, Gharbi O, Mokni M, Korbi S. Primary solid neuroendocrine carcinoma of the breast. Can J Surg 2009; 52: E289.
- 5DeGiorgi V, Grazzini M, Alfaioli B, et al. Cutaneous manifestations of breast cancer. Dermatol Ther 2010; 23: 581.
- 6Fernandez-Flores A. Cutaneous metastases: a study of 78 biopsies from 69 patients. Am J Dermatopathol 2010; 32: 222.
- 7Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 71316 cancer patients. J Am Acad Dermatol 1990; 22: 19.
- 8Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993; 29: 228.
- 9Feyter F, Hartmann G. On the carcinoid growth form of the carcinoma mammae, especially the carcinoma solidum (Gelatinosum) mammae. Frankf Z Pathol 1963; 73: 24.
- 10Cubilla AL, Woodruff JM. Primary carcinoid tumor of the breast: a report of 8 cases. Am J Surg Pathol 1977; 1: 283.
- 11Wade PM, Mills SE, Read M, Cloud W, Lambert MJ, Smith RE. Small cell neuroendocrine (oat cell) carcinoma of the breast. Cancer 1983; 52: 121.
10.1002/1097-0142(19830701)52:1<121::AID-CNCR2820520122>3.0.CO;2-F PubMed Web of Science® Google Scholar
- 12Papotti M, Macri L, Finzi G, Capella C, Eusebi V, Bussolati G. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases. Semin Diagn Pathol 1989; 6: 174.
- 13Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G. Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 2000; 17: 127.
- 14Miremadi A, Pinder SE, Lee AHS, et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 2002; 40: 215.
- 15Zekioglu O, Erhan Y, Ciris M, Bayramoglu H. Neuroendocrine differentiated carcinomas of the breast: a distinct entity. Breast 2003; 12: 251.
- 16Lopez-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernado L, Menendez JA. Solid neuroendocrine breast carcinomas: incidence, clinic-pathological features and immunohistochemical profiling. Oncol Rep 2008; 20: 1369.
- 17Wei B, Ding T, Xing Y, et al. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer 2010; 116: 4463.
- 18Jundt G, Schulz A, Heitz PU, Osborn M. Small cell neuroendocrine (oat cell) carcinoma of the male breast: immunocytochemical and ultrastructural investigations. Virchows Arch A Pathol Anat 1984; 404: 213.
- 19Papotti M, Gherardi G, Eusebi V, Pagani A, Bussolati G. Primary oat cell (neuroendocrine) carcinoma of the breast: report of four cases. Virchows Arch A Pathol Anat 1992; 420: 103.
- 20Francois A, Chatikhine VA, Chevallier B, et al. Neuroendocrine primary small cell carcinoma of the breast: report of a case and review of the literature. Am J Clin Oncol 1995; 18: 133.
- 21Fukunaga M, Ushigome S. Small cell (oat cell) carcinoma of the breast. Pathol Int 1998; 48: 744.
- 22Shin SJ, DeLellis RA, Ying L, Rosen PP. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol 2000; 24: 1231.
- 23Samli B, Celik S, Evrensel T, Orhan B, Tasdelen I. Primary neuroendocrine small cell carcinoma of the breast. Arch Pathol Lab Med 2000; 124: 296.
- 24Yamasaki T, Shimazaki H, Aida S, et al. Primary small cell (oat cell) carcinoma of the breast: report of a case and review of the literature. Pathol Int 2000; 50: 914.
- 25Bergman S, Hoda SA, Geisinger RK, Creager AJ, Trupiano JK. E-cadherin-negative primary small cell carcinoma of the breast: report of a case and review of the literature. Am J Clin Pathol 2004; 121: 117.
- 26Sridhar P, Matey P, Aluwihare N. Primary carcinoma of breast with small-cell differentiation. Breast 2004; 13: 149.
- 27Jochems L, Tjalma WAA. Primary small cell neuroendocrine tumour of the breast. Eur J Obstet Gynecol Reprod Biol 2004; 115: 231.
- 28Adegbola T, Connolly CE, Mortimer G. Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature. J Clin Pathol 2005; 58: 775.
- 29Kinoshita S, Hirano A, Komine K, et al. Primary small-cell neuroendocrine carcinoma of the breast: report of a case. Surg Today 2008; 38: 734.
- 30Latif N, Rosa M, Samian L, Rana F. An unusual case of primary small cell neuroendocrine carcinoma of the breast. Breast J 2010; 16: 647.
- 31Mecca P, Busam K. Primary male neuroendocrine adenocarcinoma involving the nipple simulating Merkel cell carcinoma – a diagnostic pitfall. J Cutan Pathol 2008; 35: 207.
- 32Shin S, DeLellis RA, Rosen PP. Small cell carcinoma of the breast – additional immunohistochemical studies. Am J Surg Pathol 2001; 25: 831.
- 33Mirza IA, Shahab N. Small cell carcinoma of the breast. Semin Oncol 2007; 34: 64.
- 34Bussolati G, Gugliotta P, Sapino A, Eusebi V, Lloyd RV. Chromogranin-reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) and normal tissue of the breast. Am J Pathol 1985; 120: 186.
- 35Rosen PP. Mammary carcinoma with endocrine features. In Rosen's breast pathology. Philadelphia: Lippincott-Raven, 1997; 431.
- 36Hoang MP, Maitra A, Gazdar AF, Albores-Saavedra J. Primary mammary small-cell carcinoma: a molecular analysis of 2 cases. Hum Pathol 2001; 32: 753.
- 37Pai RK, West RB. MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study. Appl Immunohistochem Mol Morphol 2009; 17: 202.
- 38Rogers GS, Flowers JL, Pollack SV, McCarty KS. Determination of sex steroid receptor in human basal cell carcinoma. J Am Acad Dermatol 1988; 18: 1039.
Citing Literature
